Investing Profile
Atul Deshpande
InvestorCEOGrowth Operator
CEO, IMMEDIATE Therapeutics, Drug Development and Commercialization.
immtx.comBoston, Massachusetts
Your Intro Paths to Atul Deshpande
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Current Investing Position
Managing Partner
Investment Range
$50K - $250K
Sweet Spot
$100K
Atul Deshpande is on these Sector & Stage Rankings
Atul Deshpande's Experience
Chief Executive Officer IMMEDIATE TherapeuticsPresent
Chief Strategy Officer PeptilogicsPresent
Chief Strategy Officer Harbour BiomedPresent
Dupixent - Global Operations Lead Sanofi GenzymePresent
Atul Deshpande's Education
Cranfield University - Cranfield School of Management MBA
UCI Ph.D. Neuroscience
Founders who looked at Atul Deshpande's profile also looked at these Investors
Founders who looked at Atul Deshpande's profile also looked at these Scouts & Angels